Suministro de Ranibizumab (DOE), Octreótida (DOE) suspensión y Voretigen neparvovec (DOE)

Deadline:N/A

Contract award

Estimated value
€11,678,622.02
Duration
4 years
Bidders
Awarded bidders
Name
NOVARTIS FARMACEUTICA, S.A.